Location History:
- San Marcos, CA (US) (2012)
- San Diego, CA (US) (2014)
Company Filing History:
Years Active: 2012-2014
Title: Innovations by Jonathan Edward Shelton
Introduction
Jonathan Edward Shelton is an accomplished inventor based in San Diego, CA. He has made significant contributions to the field of pharmacology, particularly in the treatment of serotonin-mediated diseases. With a total of 2 patents to his name, Shelton's work is paving the way for new therapeutic approaches.
Latest Patents
Shelton's latest patents include a groundbreaking combination therapy for patients suffering from serotonin-mediated diseases, such as depression. This innovative approach involves administering an effective combined amount of a 5-HT7 receptor antagonist and a serotonin reuptake inhibitor. Another notable patent is the chimeric peptide antagonist for GPCR135 or GPCR142. This chimeric polypeptide, R3(BΔ23-27)R/I5, is described as a high-affinity antagonist for GPCR135 and GPCR142 over LGR7.
Career Highlights
Shelton is currently associated with Janssen Pharmaceutica NV, where he continues to develop and refine his innovative ideas. His work is instrumental in advancing the understanding and treatment of complex medical conditions.
Collaborations
Some of his notable coworkers include Pascal Bonaventure and Christine Dugovic, who contribute to the collaborative environment that fosters innovation at Janssen Pharmaceutica NV.
Conclusion
Jonathan Edward Shelton's contributions to pharmacology through his patents and collaborative efforts highlight his role as a key innovator in the field. His work continues to inspire advancements in the treatment of serotonin-mediated diseases.